Fecal microbiota transplantation (FMT) is a technique used to restore the normal body flora to the gut in cases of Clostridium difficile infection (CDI). It involves instillation of the stool of a healthy donor through a nasogastric tube or colonoscopy into the gastrointestinal tract of the patient. More research is needed to determine the parameters of FMT use in patients with cancer.
At a Glance
- CDI is common in patients with cancer because of the frequent use of broad-spectrum antibiotics that can alter the normal microbiota in the gastrointestinal tract.
- CDI reoccurs frequently and can be difficult to treat.
- CDI can delay continued treatment, prolong hospitalizations, and greatly affect a patient’s quality of life.
Not a current ONS member or journal subscriber?
Receive a PDF to download and print.
Fecal Microbiota Transplantation in Patients With Cancer Undergoing Treatment
has been added to your cart